Establishment of Two Kinds of Lung Cancer Models in Mouse and Evaluation by Micro PET-CT

doi:10.3969/j.issn.1674-5817.2019.01.008

Abstract

Abstract: Objective To compare the difference of two kinds of lung cancer models in mouse, which were established by injecting with the human non-small cell lung cancer (NSCLC) cells through tail vein or orthotopically inoculating in the lung using a microsyringe through the intercostals space. Methods The NCI-H1975 cells of NSCLC were injected into the NOD-SCID mouse via tail vein or intercostals space. After 15 days, mice were scanned by micro PET-CT to monitor the tumor growth and metastasis. Then mice were sacrificed and their lungs were dissected, fixed with phosphate-buffered neutral formalin and prepared for standard histological examination. Results Mice that were injected with the NCI-H1975 cells through tail vein for 15 days did not form tumor nodules on the lung. However, the mice that were orthotopically inoculated in the lung through intercostals space significantly had tumor nodules in their lungs. Conclusion A NOD-SCID mouse lung tumor model can be successfully established by transplanting NCI-H1975 cells into the lung through intercostals space. This model is simple, repeatable, and efficient.

Key words: Mouse orthotopic lung cancer model, Micro PET-CT, Tail intravenous injection

CLC Number:

Q95-33

SHEN Yan, WANG Yun, ZHANG Ru, RUAN Zheng, MAO Jian-hua. Establishment of Two Kinds of Lung Cancer Models in Mouse and Evaluation by Micro PET-CT[J]. Laboratory Animal and Comparative Medicine, 2019, 39(1): 39-45.

References

[1] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66(1):7-30.
[2] Herbst RS, Heymach JV, Lippman SM.Lung cancer[J]. N Engl J Med, 2008, 359(13):1367-1380.
[3] 胥孜杭, 胡洁淼, 陈晓, 等. 小鼠肺癌模型研究进展[J]. 中国医药导报, 2016, 13(9):63-67.
[4] 刘馨, 伍治平, 左曙光, 等. 小鼠Lewis肺癌原位模型的构建[J]. 中国肺癌杂志, 2010, 13(1):42-47.
[5] Sharma S, Gao P, Steele VE.The chemopreventive efficacy of inhaled oltipraz particulates in the B[a] P-induced A/J mouse lung adenoma model[J]. Carcinogenesis, 2006, 27(8): 1721-1727.
[6] 候敏, 戴丽军, 黄健清. 化学致癌剂诱发的小鼠肺癌模型及应用研究[J]. 医学综述, 2015, 4(21):615-617.
[7] 顾其华, 胡成平, 夏莹, 等. 3,4-苯并芘肺内注射构建大鼠肺肿瘤模型的实验研究[J]. 中国肺癌杂志, 2007, 10(3):172-175.
[8] Iochmann S, Lerondel S, Bléchet C, et al.Monitoring of tumor progression using bioluminescence imaging and computed tomography scanning in a nude mouse orthotopic model of human small cell lung cancer[J]. Lung Cancer, 2012, 77(1): 70-76.
[9] 张贺龙, 矢野圣二, 三木丰和. 经气管接种肺癌细胞建立肺癌动物模型的经验教训[J]. 第四军医大学学报, 2002, 23(17):1586.
[10] 张修彦, 詹纯列. 转基因肺癌动物模型研究进展[J]. 中国比较医学杂志, 2012, 22(10):64-66.
[11] Regales L, Balak MN, Gong Y, et al.Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors[J]. PLoS One, 2007, 2(8):e810.
[12] 胥孜杭, 刘菲, 邹纯朴, 等. 小鼠肺癌原位模型的建立[J]. 中国医药导报, 2015, 12(1):15-19.
[13] 李天然, 田嘉禾. 小动物PET及PET-CT及其在分子影像学中的应用[J]. 国际放射医学核医学杂志, 2008, 32(1):1-4.
[14] Liang H, Yang Y, Yang K, et al.A microPET/CT system for in vivo small animal imaging[J]. Phys Med Biol, 2007, 52(13):3881-3894.
[15] Haberkorn U, Eisenhut M, Altmann A, et al.Endoradiotherapy with peptides-status and future development[J]. Curr Med Chem, 2008, 15(3):219-234.
[16] Cai W, Zhang X, Wu Y, et al.A thiol-reactive 18F-labeling agent, N-[2-(4-18F-Fluorobenzamido)ethyl] maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression[J]. J Nucl Med, 2006, 47(7):1172-1180.
[17] Wang H, Cai W, Chen K, et al.A new PET tracer specific for vascular endothelial growth factor receptor 2[J]. Eur J Nucl Med Mol Imaging, 2007, 34(12):2001-2010.
[18] 陈愉生, 林小芬, 李鸿茹, 等. 肺癌转移瘤动物模型的建立[J]. 中国实验动物学报, 2014, 22(5):32-34.
[19] Vertrees RA, Deyo DJ, Quast M, et al.Development of a human to murine orthotopic xenotransplanted lung cancer model[J]. J Invest Surg, 2000, 13(6):349-358.
[20] Ting G, Chang CH, Wang HE.Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy[J]. Anticancer Res, 2009, 29(10):4107-4118.
[21] Shu CJ, Guo S, Kim YJ, et al.Visualization of a primary anti-tumor immune response by positron emission tomography[J]. Proc Natl Acad Sci USA, 2005, 102(48):17412-17417.
[22] Bérard V, Rousseau JA, Cadorette J, et al.Dynamic imaging of transient metabolic processes by small-animal PET for the evaluation of photosensitizers in photodynamic therapy of cancer[J]. J Nucl Med, 2006, 47(7):1119-1126.
[23] Wängler C, Buchmann I, Eisenhut M, et al.Radiolabeled peptides and proteins in cancer therapy[J]. Protein Pept Lett, 2007, 14(3):273-279.